HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies

Ahmed El-Gohary, Abdel Moneim Hosny, Naglaa Fawaz, Anwar Heiba, Essam Abdalla, Fumio Kawano, Tetsuyuki Kiyokawa

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The hepatitis C virus (HCV) infection is associated with a wide spectrum of clinical entities ranging from asymptomatic carriage to severe forms of chronic hepatitis. In Egypt, HCV infection has been shown to be highly prevalent. The aim of this study was to determine the frequency and significance of anti-HCV IgM in the sera of clinically healthy blood donors and chronic HCV patients, whose sera were also positive for anti-HCV IgG. Anti-HCV IgM was detected in the sera of 7 (46%) of the blood donors (n = 15), of whom 5 (71%) had a positive HCV-RNA. The corresponding results in patients with a chronic hepatitis C (CHC) infection (n = 19) were 8 (42%) and 5 (62%) respectively. The detection of anti-HCV IgM did not correlate with a positive test for HCV-RNA (R = 0.2) in the CHC patients. However, the levels of anti-HCV IgM in CHC patients were associated significantly with the level of serum transaminase, a finding that can be used in monitoring disease activity in such a group of patients. On the other hand, a significant association was evident between the detection of anti-HCV IgM and HCV-RNA in the sera of blood donors. Thus among the blood donors, viraemia correlates well with the detection of HCV-IgM Ab, but it cannot be excluded in its absence. The presence of HCV-IgM in some patients with CHC infection indicates that the antibody as a viral marker may not be unique to acute HCV infection.

Original languageEnglish
Pages (from-to)113-116
Number of pages4
JournalJapanese Journal of Infectious Diseases
Volume52
Issue number3
Publication statusPublished - Jun 1999

Fingerprint

Hepatitis C Antibodies
Hepacivirus
Immunoglobulin M
Immunoglobulin G
RNA
Chronic Hepatitis C
Blood Donors
Virus Diseases
Serum
Egypt
Viremia
Chronic Hepatitis
Transaminases
Infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

El-Gohary, A., Hosny, A. M., Fawaz, N., Heiba, A., Abdalla, E., Kawano, F., & Kiyokawa, T. (1999). HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies. Japanese Journal of Infectious Diseases, 52(3), 113-116.

HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies. / El-Gohary, Ahmed; Hosny, Abdel Moneim; Fawaz, Naglaa; Heiba, Anwar; Abdalla, Essam; Kawano, Fumio; Kiyokawa, Tetsuyuki.

In: Japanese Journal of Infectious Diseases, Vol. 52, No. 3, 06.1999, p. 113-116.

Research output: Contribution to journalArticle

El-Gohary, A, Hosny, AM, Fawaz, N, Heiba, A, Abdalla, E, Kawano, F & Kiyokawa, T 1999, 'HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies', Japanese Journal of Infectious Diseases, vol. 52, no. 3, pp. 113-116.
El-Gohary A, Hosny AM, Fawaz N, Heiba A, Abdalla E, Kawano F et al. HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies. Japanese Journal of Infectious Diseases. 1999 Jun;52(3):113-116.
El-Gohary, Ahmed ; Hosny, Abdel Moneim ; Fawaz, Naglaa ; Heiba, Anwar ; Abdalla, Essam ; Kawano, Fumio ; Kiyokawa, Tetsuyuki. / HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies. In: Japanese Journal of Infectious Diseases. 1999 ; Vol. 52, No. 3. pp. 113-116.
@article{611e808a65e74ec49d60692f7c423b96,
title = "HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies",
abstract = "The hepatitis C virus (HCV) infection is associated with a wide spectrum of clinical entities ranging from asymptomatic carriage to severe forms of chronic hepatitis. In Egypt, HCV infection has been shown to be highly prevalent. The aim of this study was to determine the frequency and significance of anti-HCV IgM in the sera of clinically healthy blood donors and chronic HCV patients, whose sera were also positive for anti-HCV IgG. Anti-HCV IgM was detected in the sera of 7 (46{\%}) of the blood donors (n = 15), of whom 5 (71{\%}) had a positive HCV-RNA. The corresponding results in patients with a chronic hepatitis C (CHC) infection (n = 19) were 8 (42{\%}) and 5 (62{\%}) respectively. The detection of anti-HCV IgM did not correlate with a positive test for HCV-RNA (R = 0.2) in the CHC patients. However, the levels of anti-HCV IgM in CHC patients were associated significantly with the level of serum transaminase, a finding that can be used in monitoring disease activity in such a group of patients. On the other hand, a significant association was evident between the detection of anti-HCV IgM and HCV-RNA in the sera of blood donors. Thus among the blood donors, viraemia correlates well with the detection of HCV-IgM Ab, but it cannot be excluded in its absence. The presence of HCV-IgM in some patients with CHC infection indicates that the antibody as a viral marker may not be unique to acute HCV infection.",
author = "Ahmed El-Gohary and Hosny, {Abdel Moneim} and Naglaa Fawaz and Anwar Heiba and Essam Abdalla and Fumio Kawano and Tetsuyuki Kiyokawa",
year = "1999",
month = "6",
language = "English",
volume = "52",
pages = "113--116",
journal = "Japanese Journal of Infectious Diseases",
issn = "1344-6304",
publisher = "National Institute of Health",
number = "3",

}

TY - JOUR

T1 - HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies

AU - El-Gohary, Ahmed

AU - Hosny, Abdel Moneim

AU - Fawaz, Naglaa

AU - Heiba, Anwar

AU - Abdalla, Essam

AU - Kawano, Fumio

AU - Kiyokawa, Tetsuyuki

PY - 1999/6

Y1 - 1999/6

N2 - The hepatitis C virus (HCV) infection is associated with a wide spectrum of clinical entities ranging from asymptomatic carriage to severe forms of chronic hepatitis. In Egypt, HCV infection has been shown to be highly prevalent. The aim of this study was to determine the frequency and significance of anti-HCV IgM in the sera of clinically healthy blood donors and chronic HCV patients, whose sera were also positive for anti-HCV IgG. Anti-HCV IgM was detected in the sera of 7 (46%) of the blood donors (n = 15), of whom 5 (71%) had a positive HCV-RNA. The corresponding results in patients with a chronic hepatitis C (CHC) infection (n = 19) were 8 (42%) and 5 (62%) respectively. The detection of anti-HCV IgM did not correlate with a positive test for HCV-RNA (R = 0.2) in the CHC patients. However, the levels of anti-HCV IgM in CHC patients were associated significantly with the level of serum transaminase, a finding that can be used in monitoring disease activity in such a group of patients. On the other hand, a significant association was evident between the detection of anti-HCV IgM and HCV-RNA in the sera of blood donors. Thus among the blood donors, viraemia correlates well with the detection of HCV-IgM Ab, but it cannot be excluded in its absence. The presence of HCV-IgM in some patients with CHC infection indicates that the antibody as a viral marker may not be unique to acute HCV infection.

AB - The hepatitis C virus (HCV) infection is associated with a wide spectrum of clinical entities ranging from asymptomatic carriage to severe forms of chronic hepatitis. In Egypt, HCV infection has been shown to be highly prevalent. The aim of this study was to determine the frequency and significance of anti-HCV IgM in the sera of clinically healthy blood donors and chronic HCV patients, whose sera were also positive for anti-HCV IgG. Anti-HCV IgM was detected in the sera of 7 (46%) of the blood donors (n = 15), of whom 5 (71%) had a positive HCV-RNA. The corresponding results in patients with a chronic hepatitis C (CHC) infection (n = 19) were 8 (42%) and 5 (62%) respectively. The detection of anti-HCV IgM did not correlate with a positive test for HCV-RNA (R = 0.2) in the CHC patients. However, the levels of anti-HCV IgM in CHC patients were associated significantly with the level of serum transaminase, a finding that can be used in monitoring disease activity in such a group of patients. On the other hand, a significant association was evident between the detection of anti-HCV IgM and HCV-RNA in the sera of blood donors. Thus among the blood donors, viraemia correlates well with the detection of HCV-IgM Ab, but it cannot be excluded in its absence. The presence of HCV-IgM in some patients with CHC infection indicates that the antibody as a viral marker may not be unique to acute HCV infection.

UR - http://www.scopus.com/inward/record.url?scp=0032869332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032869332&partnerID=8YFLogxK

M3 - Article

C2 - 10507990

AN - SCOPUS:0032869332

VL - 52

SP - 113

EP - 116

JO - Japanese Journal of Infectious Diseases

JF - Japanese Journal of Infectious Diseases

SN - 1344-6304

IS - 3

ER -